Platelet Transfusion

Known as: Transfusions, Platelet, Platelet Transfusions, Platelet Transfusions, Blood 
The transfer of blood platelets from a donor to a recipient or reinfusion to the donor.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
BACKGROUND The effectiveness of platelet transfusions to prevent bleeding in patients with hematologic cancers remains unclear… (More)
  • table 3
  • figure 1
  • table 1
  • table 3
  • table 3
Is this relevant?
Highly Cited
2010
Highly Cited
2010
BACKGROUND We conducted a trial of prophylactic platelet transfusions to evaluate the effect of platelet dose on bleeding in… (More)
  • table 1
  • table 1
  • table 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2009
Highly Cited
2009
BACKGROUND Platelet transfusions have been identified as an independent risk factor for survival after orthotopic liver… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
2007
Highly Cited
2007
BACKGROUND Transfusion has long been identified as a risk factor for acute lung injury (ALI)/ARDS. No study has formally… (More)
Is this relevant?
Highly Cited
2006
Highly Cited
2006
Toll-like receptors (TLRs) play a critical role in stimulating innate immunity by recognizing pathogen-associated molecular… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 6
Is this relevant?
Highly Cited
2005
Highly Cited
2005
A variety of patient and product-related factors influenced the outcome of 6379 transfusions given to 533 patients in the Trial… (More)
  • table 2
  • table 4
  • table 5
  • table 6
Is this relevant?
Highly Cited
2003
Highly Cited
2003
A nucleic acid-targeted photochemical treatment (PCT) using amotosalen HCl (S-59) and ultraviolet A (UVA) light was developed to… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2001
Highly Cited
2001
Thalidomide was administered to 83 patients with myelodysplastic syndrome (MDS), starting at 100 mg by mouth daily and increasing… (More)
  • table 1
  • table 2
  • figure 2
  • figure 1
  • table 3
Is this relevant?
Highly Cited
1997
Highly Cited
1997
  • The New England journal of medicine
  • 1997
BACKGROUND We conducted a multi-institutional, randomized, blinded trial to determine whether the use of platelets from which… (More)
Is this relevant?
Highly Cited
1997
Highly Cited
1997
BACKGROUND Prophylactic platelet transfusions are usually administered to patients receiving myelotoxic chemotherapy when their… (More)
Is this relevant?